ARTICLE | Clinical News
hc2 High-Risk human papillomavirus regulatory update
December 8, 2003 8:00 AM UTC
DIGE received European CE Mark approval for its patient screening tests. The CE Mark means the tests comply with European regulatory requirements and allows DIGE to continue selling the HPV, chlamydia...